| GABFX | PIPNX | GABFX / PIPNX | |
| Total Expense Ratio | 0.37 | 0.69 | 54% |
| Annual Report Gross Expense Ratio | 0.66 | 0.74 | 89% |
| Fund Existence | 17 years | 8 years | - |
| Gain YTD | -6.639 | 0.500 | -1,327% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 300000000 | 1000000 | 30,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | N/A | 230B | - |
| Annual Yield % from dividends | 2.96 | 5.63 | 53% |
| Returns for 1 year | -5.05 | 4.23 | -119% |
| Returns for 3 years | -2.58 | 23.01 | -11% |
| Returns for 5 years | -18.64 | 18.61 | -100% |
| Returns for 10 years | 2.30 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RCLR | 51.55 | N/A | N/A |
| Reckoner BBB-B Clo Reinvesting ETF | |||
| QNXT | 32.03 | -0.41 | -1.25% |
| iShares Nasdaq-100 ex Top 30 ETF | |||
| FVC | 42.25 | -0.74 | -1.72% |
| First Trust Dorsey Wright Dynamic Foc 5 | |||
| AMDY | 42.15 | -0.86 | -2.00% |
| YieldMax AMD Option Income Strategy ETF | |||
| ARKG | 47.64 | -2.23 | -4.47% |
| ARK Genomic Revolution ETF | |||